Redhill Biopharma Announced Issue Of New U.S. Patent Covering Talicia As An All-in-one Fixed-dose Combination Of Amoxicillin, Omeprazole And Rifabutin And Its Use For Helicobacter Pylori; Expected To Provide Protection For Talicia Until Feb 12, 2034
Redhill Biopharma宣佈發佈新的美國專利，涵蓋塔利西亞作爲阿莫西林、奧美拉唑和利福布汀的一體化固定劑量組合物及其用於幽門螺桿菌的用途；預計將在2034年2月12日之前爲塔利西亞提供保護